HELPING THE OTHERS REALIZE THE ADVANTAGES OF LDN-27219 AS A CANCER DRUG CANDIDATE

In contrast to neurodegerative illnesses and cancer, the contribution of TG2 activity to celiac sprue pathogenesis has actually been fairly perfectly established. The deamidation of particular glutamine residues targeted by TG2 in gluten peptides has long been shown to improve peptide binding to the disease-associated proteins HLA-DQ2/eight, which